Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 12/20 | 0.67 |
| ▸ | VDR | P11473 | 10/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19460228 | 1.00 | AR (0.67) | ARVDRKDM4ECYP1A2 | |
| SCHEMBL19459647 | 1.00 | AR (0.67) | ARVDRKDM4ECYP1A2 | |
| SCHEMBL30816338 | 1.00 | AR (0.67) | ARVDRKDM4ECYP1A2 | |
| SCHEMBL19483474 | 1.00 | AR (0.67) | ARVDRKDM4ECYP1A2 | |
| SCHEMBL19459816 | 1.00 | AR (0.67) | ARVDRKDM4ECYP1A2 | |
| SCHEMBL30816341 | 1.00 | AR (0.67) | ARVDRKDM4ECYP1A2 | |
| SCHEMBL30816371 | 1.00 | AR (0.67) | ARVDRKDM4ECYP1A2 | |
| SCHEMBL19459687 | 1.00 | AR (0.67) | ARVDRKDM4ECYP1A2 | |
| SCHEMBL19459648 | 1.00 | AR (0.67) | ARVDRKDM4ECYP1A2 | |
| SCHEMBL16688238 | 0.94 | AR (0.79) | ARVDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250100986-A1 | BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2025-03-27 | — | — | US | disclosed |
| US-11919874-B2 | Bisphenol derivatives and their use as androgen receptor activity modulators | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2024-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250100986-A1 | BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS | AR, SHBG, NR5A1 | AR 1/4885VDR 28/4885KDM4E 2560/4885 |
| US-11919874-B2 | Bisphenol derivatives and their use as androgen receptor activity modulators | AR, SHBG, NR5A1 | AR 1/4885VDR 28/4885KDM4E 2560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.